Who
Jeffrey Alan Jones
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Cullinan Therapeutics.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $444K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Feb 2022
- Last trade
- 24 Feb 2026
- Last filed
- 25 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Feb 2026filed 25 Feb 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $66K4,582 at $14.47 | filing |
| 24 Feb 2026filed 25 Feb 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $66K4,582 at $14.47 | filing |
| 20 Feb 2026filed 23 Feb 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $68K4,982 at $13.62 | filing |
| 20 Feb 2026filed 23 Feb 2026 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $68K4,982 at $13.62 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 18 Dec 2025filed 19 Dec 2025 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $45K4,632 at $9.67 | filing |
| 25 Feb 2025filed 27 Feb 2025 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $42K4,895 at $8.53 | filing |
| 19 Feb 2025filed 21 Feb 2025 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 18 Dec 2024filed 20 Dec 2024 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $53K4,632 at $11.41 | filing |
| 22 Feb 2024filed 23 Feb 2024 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 22 Feb 2024filed 23 Feb 2024 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 21 Dec 2023filed 22 Dec 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $16K1,860 at $8.50 | filing |
| 18 Dec 2023filed 20 Dec 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,173386 at $8.22 | filing |
| 20 Jun 2023filed 21 Jun 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,008387 at $12.94 | filing |
| 18 May 2023filed 19 May 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,451394 at $8.76 | filing |
| 18 Apr 2023filed 20 Apr 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,198392 at $10.71 | filing |
| 20 Mar 2023filed 27 Mar 2023 | CGEM Cullinan TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,415390 at $11.32 | filing |
| 17 Feb 2023filed 21 Feb 2023 | CGEM Cullinan Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.